Related by context. Frequent words. (Click for all words.) 77 Sol J. Barer 73 Steve Worland Ph.D. 73 Dino Dina 72 J. Donald deBethizy 71 Francois Nader 71 Michael H. Tardugno 70 Dr. Randall Yatscoff 70 Edward Lanphier Sangamo 70 Sachiko Kuno Ph.D. 69 Dr. Rahul Singhvi 69 Jeffrey H. Buchalter 69 John Maraganore Ph.D. 68 Brian JG Pereira 68 Clay B. Siegall 68 Steven A. Kriegsman 68 Chemokine Therapeutics 68 Jack Lief Arena 67 Onno van de Stolpe 67 George A. Scangos 67 Kevin Buchi 67 Receptos 67 Aegerion 67 Thomas B. Okarma 67 Simon Sturge 66 Matthew Emmens 66 Genaera Corporation 66 Frank Baldino Jr. 66 Jean Jacques Bienaime 66 Altus Pharmaceuticals 66 MultiCell Technologies 66 Æterna Zentaris 66 Neogenix 66 Ampio 66 Cerus Corporation 66 Jack Lief 65 Ueno founded 65 Genitope Corporation 65 Jean Paul Clozel 65 Kauffman MD Ph.D. 65 Regado Biosciences 65 Martin Madaus 65 Eamonn Hobbs 65 Daniel Von Hoff 65 QuatRx 65 Bayhill Therapeutics 65 Patrick J. Balthrop 65 Elusys 64 Raymond P. Warrell 64 Sunesis Pharmaceuticals 64 Dynogen 64 ANAVEX 64 Arthur S. Przybyl 64 FluoroPharma 64 NASDAQ LGND 64 Peptimmune 64 Vaccinex 64 Inc. NASDAQ EXEL 64 Relypsa 64 Hybridon 64 Akesis 64 Inc Therapeutic Competitors 64 ACLARA 64 NovaBay Pharmaceuticals 64 ImmunoCellular Therapeutics 63 SCOLR Pharma 63 Quark Pharmaceuticals 63 Adventrx 63 AVEO Pharmaceuticals 63 Cyclacel Pharmaceuticals 63 Diatos 63 Syntonix 63 MacuSight 63 Trofex 63 Ardea Biosciences 63 ViaCyte 63 PsychoGenics 63 Randal Mills 63 Cempra 63 Cempra Pharmaceuticals 63 A. Pontius 63 Nanobiotix 63 Aerovance 62 Elixir Pharmaceuticals 62 Taligen 62 Emisphere Technologies 62 Initiates Phase II 62 www.vivus.com 62 Preclinical Development 62 Inc. Nasdaq IMGN 62 VIRxSYS 62 Susan Desmond Hellmann 62 Intarcia 62 Ligand Pharmaceuticals Incorporated 62 Lisa N. Drakeman 62 Gilles Gagnon 62 Aegera 62 Idera Pharmaceuticals 62 Panzem R 62 Amorcyte 62 Stephen M. Simes 62 Alnara